Targeted Protein Degradation Of Parp14 For Use In Therapy - EP3986887
The patent EP3986887 was granted to Abbvie Biotechnology on Apr 27, 2022. The application was originally filed on Jun 18, 2020 under application number EP20737701A. The patent is currently recorded with a legal status of "Request For Examination Was Made".
EP3986887
- Application Number
- EP20737701A
- Filing Date
- Jun 18, 2020
- Status
- Request For Examination Was Made
- Mar 25, 2022
- Grant Date
- Apr 27, 2022
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents